Skip to main content

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 861177 NEW YORK, NY

Position in TEVA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$129,843,910
+$128,119,721 QoQ
Shares Held
3,832,465
+6595.0% QoQ
Ownership
0.329%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#32
of 671 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 38% Shared 0% None 62%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $852,377,607 across 33 Drug Manufacturers - Specialty & Generic names. TEVA ranks #2 (15.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 TEVA
Teva Pharmaceutical Industries Ltd
This page
3,832,465 $129,843,910

All Filings in TEVA

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $129,843,910 3,832,465
2026-03-31 $1,724,189 57,244
2025-12-31 $176,461 5,654
2025-09-30 $1,114,999 55,198
2025-06-30 $78,298,273 4,671,735
2025-03-31 $54,368,664 3,537,324
2024-12-31 $73,637,024 3,341,063
2024-09-30 $60,862,850 3,377,517
2024-06-30 $16,263,795 1,000,849
2024-03-31 $31,373,073 2,223,464
2023-12-31 $23,625,193 2,262,950
2023-09-30 $23,361,576 2,290,351
2023-06-30 $14,446,173 1,918,483
2023-03-31 $16,978,571 1,918,483
2022-12-31 $16,693,300 1,830,406
2022-09-30 $13,535,202 1,677,225
2022-06-30 $13,579,160 1,805,740
2022-03-31 $16,899,743 1,799,760
2021-12-31 $15,142,700 1,890,475
2021-09-30 $18,640,799 1,913,840
2021-06-30 $17,651,379 1,782,968
2021-03-31 $21,600,858 1,871,825
2020-12-31 $18,650,359 1,932,680
2020-09-30 $17,572,110 1,950,290
2020-06-30 $23,863,196 1,935,377
2020-03-31 $17,900,342 1,993,357